All changes for the tissue urinary system (132)
Identifier
Name
Type
Tissues
Organism
Gene
Data
Actions
DAA1479
predicted gene 5537
Molecular
kidney
Mouse
Gm5537
4.0% Decrease Gene Expression Level
DAA1466
prominin 1
Molecular
kidney
Mouse
Prom1
8.0% Increase Gene Expression Level
DAA1452
RAB31, member RAS oncogene family
Molecular
kidney
Mouse
Rab31
6.0% Increase Gene Expression Level
DAA278
Ras-related GTP binding D
Molecular
kidney
Human
RRAGD
14.0% Decrease Gene Expression Level
DAA2020
Reduction in renal function
Physiological
kidney
Human
—
—
DAA886
Renal arteriosclerosis
Pathological
renal vasculature
Human
—
—
DAA885
Renal blood flow declines
Physiological
renal vasculature
Human
—
—
DAA640
Renal failure
Pathological
kidney
Human
—
SeriesMorbidity
DAA897
Response to antidiuretic hormone decreased
Physiological
renal tubule
Human
—
—
DAA276
Rh family, C glycoprotein
Molecular
kidney
Human
RHCG
16.0% Decrease Gene Expression Level
DAA1481
RIKEN cDNA 0610011F06 gene
Molecular
kidney
Mouse
0610011F06Rik
6.0% Decrease Gene Expression Level
DAA1457
RIKEN cDNA 9530001N24 gene
Molecular
kidney
Mouse
9530001N24Rik
3.0% Decrease Gene Expression Level
DAA1499
RIKEN cDNA C430014B12 gene
Molecular
kidney
Mouse
C430014B12Rik
26.0% Increase Gene Expression Level
DAA1448
RIKEN cDNA C730048C13 gene
Molecular
kidney
Mouse
C730048C13Rik
7.0% Decrease Gene Expression Level
DAA1451
RIKEN cDNA E030003E18 gene
Molecular
kidney
Mouse
E030003E18Rik
11.0% Increase Gene Expression Level
DAA1456
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D
Molecular
kidney
Mouse
Sema4d
4.0% Increase Gene Expression Level
DAA282
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5
Molecular
kidney
Human
SERPINA5
11.0% Decrease Gene Expression Level
DAA898
Sodium conservation decreased
Physiological
renal tubule
Human
—
—
DAA268
solute carrier family 12 (sodium/chloride transporters), member 3
Molecular
kidney
Human
SLC12A3
16.0% Decrease Gene Expression Level
DAA1449
spastic paraplegia 21 homolog (human)
Molecular
kidney
Mouse
Spg21
5.0% Decrease Gene Expression Level
DAA902
specific activities of enzymes are reduced
Molecular
kidney
Human
—
—
DAA286
StAR-related lipid transfer (START) domain containing 8
Molecular
kidney
Human
STARD8
14.0% Decrease Gene Expression Level
DAA901
telomere shortening
Molecular
kidney
Human
—
—
DAA1490
thymosin, beta 10
Molecular
kidney
Mouse
Tmsb10
12.0% Increase Gene Expression Level
DAA904
Transport maximum for glucose declines
Physiological
renal tubule
Human
—
—
Identifier | Name | Type | Tissues | Organism | Gene | Data | Actions |
---|---|---|---|---|---|---|---|
DAA1479 | predicted gene 5537 | Molecular | kidney | Mouse | Gm5537 | 4.0% Decrease Gene Expression Level | |
DAA1466 | prominin 1 | Molecular | kidney | Mouse | Prom1 | 8.0% Increase Gene Expression Level | |
DAA1452 | RAB31, member RAS oncogene family | Molecular | kidney | Mouse | Rab31 | 6.0% Increase Gene Expression Level | |
DAA278 | Ras-related GTP binding D | Molecular | kidney | Human | RRAGD | 14.0% Decrease Gene Expression Level | |
DAA2020 | Reduction in renal function | Physiological | kidney | Human | — | — | |
DAA886 | Renal arteriosclerosis | Pathological | renal vasculature | Human | — | — | |
DAA885 | Renal blood flow declines | Physiological | renal vasculature | Human | — | — | |
DAA640 | Renal failure | Pathological | kidney | Human | — | SeriesMorbidity | |
DAA897 | Response to antidiuretic hormone decreased | Physiological | renal tubule | Human | — | — | |
DAA276 | Rh family, C glycoprotein | Molecular | kidney | Human | RHCG | 16.0% Decrease Gene Expression Level | |
DAA1481 | RIKEN cDNA 0610011F06 gene | Molecular | kidney | Mouse | 0610011F06Rik | 6.0% Decrease Gene Expression Level | |
DAA1457 | RIKEN cDNA 9530001N24 gene | Molecular | kidney | Mouse | 9530001N24Rik | 3.0% Decrease Gene Expression Level | |
DAA1499 | RIKEN cDNA C430014B12 gene | Molecular | kidney | Mouse | C430014B12Rik | 26.0% Increase Gene Expression Level | |
DAA1448 | RIKEN cDNA C730048C13 gene | Molecular | kidney | Mouse | C730048C13Rik | 7.0% Decrease Gene Expression Level | |
DAA1451 | RIKEN cDNA E030003E18 gene | Molecular | kidney | Mouse | E030003E18Rik | 11.0% Increase Gene Expression Level | |
DAA1456 | sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D | Molecular | kidney | Mouse | Sema4d | 4.0% Increase Gene Expression Level | |
DAA282 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 | Molecular | kidney | Human | SERPINA5 | 11.0% Decrease Gene Expression Level | |
DAA898 | Sodium conservation decreased | Physiological | renal tubule | Human | — | — | |
DAA268 | solute carrier family 12 (sodium/chloride transporters), member 3 | Molecular | kidney | Human | SLC12A3 | 16.0% Decrease Gene Expression Level | |
DAA1449 | spastic paraplegia 21 homolog (human) | Molecular | kidney | Mouse | Spg21 | 5.0% Decrease Gene Expression Level | |
DAA902 | specific activities of enzymes are reduced | Molecular | kidney | Human | — | — | |
DAA286 | StAR-related lipid transfer (START) domain containing 8 | Molecular | kidney | Human | STARD8 | 14.0% Decrease Gene Expression Level | |
DAA901 | telomere shortening | Molecular | kidney | Human | — | — | |
DAA1490 | thymosin, beta 10 | Molecular | kidney | Mouse | Tmsb10 | 12.0% Increase Gene Expression Level | |
DAA904 | Transport maximum for glucose declines | Physiological | renal tubule | Human | — | — |